It was reported that rAd.DCN inhibited tumour growth and metastasis as a consequence of decorin interfering with wnt/β-catenin, vascular endothelial growth factor (VEGF), the Met pathways and by modulating anti-tumour inflammatory and immune responses (Zhao et al., 2019). This evidence concerns the gene VEGFA and neoplasm.